Movement disorder emergencies in childhood

Abstract The literature on paediatric acute-onset movement disorders is scattered. In a prospective cohort of 52 children (21 male; age range 2mo-15y), the commonest were chorea, dystonia, tremor, myoclonus, and Parkinsonism in descending order of frequency. In this series of mainly previously well...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of paediatric neurology 2011-09, Vol.15 (5), p.390-404
Hauptverfasser: Kirkham, F.J, Haywood, P, Kashyape, P, Borbone, J, Lording, A, Pryde, K, Cox, M, Keslake, J, Smith, M, Cuthbertson, L, Murugan, V, Mackie, S, Thomas, N.H, Whitney, A, Forrest, K.M, Parker, A, Forsyth, R, Kipps, C.M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 404
container_issue 5
container_start_page 390
container_title European journal of paediatric neurology
container_volume 15
creator Kirkham, F.J
Haywood, P
Kashyape, P
Borbone, J
Lording, A
Pryde, K
Cox, M
Keslake, J
Smith, M
Cuthbertson, L
Murugan, V
Mackie, S
Thomas, N.H
Whitney, A
Forrest, K.M
Parker, A
Forsyth, R
Kipps, C.M
description Abstract The literature on paediatric acute-onset movement disorders is scattered. In a prospective cohort of 52 children (21 male; age range 2mo-15y), the commonest were chorea, dystonia, tremor, myoclonus, and Parkinsonism in descending order of frequency. In this series of mainly previously well children with cryptogenic acute movement disorders, three groups were recognised: (1) Psychogenic disorders ( n  = 12), typically >10 years of age, more likely to be female and to have tremor and myoclonus (2) Inflammatory or autoimmune disorders ( n  = 22), including N-methyl- d -aspartate receptor encephalitis, opsoclonus-myoclonus, Sydenham chorea, systemic lupus erythematosus, acute necrotizing encephalopathy (which may be autosomal dominant), and other encephalitides and (3) Non-inflammatory disorders ( n  = 18), including drug-induced movement disorder, post-pump chorea, metabolic, e.g. glutaric aciduria, and vascular disease, e.g. moyamoya. Other important non-inflammatory movement disorders, typically seen in symptomatic children with underlying aetiologies such as trauma, severe cerebral palsy, epileptic encephalopathy, Down syndrome and Rett syndrome, include dystonic posturing secondary to gastro-oesophageal reflux (Sandifer syndrome) and Paroxysmal Autonomic Instability with Dystonia (PAID) or autonomic ‘storming’. Status dystonicus may present in children with known extrapyramidal disorders, such as cerebral palsy or during changes in management e.g. introduction or withdrawal of neuroleptic drugs or failure of intrathecal baclofen infusion; the main risk in terms of mortality is renal failure from rhabdomyolysis. Although the evidence base is weak, as many of the inflammatory/autoimmune conditions are treatable with steroids, immunoglobulin, plasmapheresis, or cyclophosphamide, it is important to make an early diagnosis where possible. Outcome in survivors is variable. Using illustrative case histories, this review draws attention to the practical difficulties in diagnosis and management of this important group of patients.
doi_str_mv 10.1016/j.ejpn.2011.04.005
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_904483521</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1090379811000766</els_id><sourcerecordid>904483521</sourcerecordid><originalsourceid>FETCH-LOGICAL-c442t-18938af6406e90ebe8c965c4a3d97937dba188ac735fa0f7afbeff1d39a7a9213</originalsourceid><addsrcrecordid>eNqNkU1LAzEYhIMoWqt_wIP0Jgi7vtlkPwIiSPELFA_qOaTJuzbrdlOTttB_b5ZWDx5ECCSBmWF4hpATCikFWlw0KTbzLs2A0hR4CpDvkAHNWZZklMFufIOAhJWiOiCHITQAIHhW7JODjFYsL_JyQM6f3Apn2C1GxgbnDfpR_Pp37LTFMLLdSE9ta6bOmSOyV6s24PH2HpK325vX8X3y-Hz3ML5-TDTn2SKhlWCVqgsOBQrACVZaFLnmihlRClaaiaJVpXTJ8lpBXap6gnVNDROqVCI2H5KzTe7cu88lhoWc2aCxbVWHbhmkAM5j_X8oYxMRT55HZbZRau9C8FjLubcz5deSguxhykb2MGUPUwKXEWY0nW7jl5MZmh_LN70ouNwIMOJYWfQyRGqdRmM96oU0zv6df_XLrlvbWa3aD1xjaNzSdxG0pDJkEuRLP2e_JqVxybIo2BdsKJlw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>893993955</pqid></control><display><type>article</type><title>Movement disorder emergencies in childhood</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Kirkham, F.J ; Haywood, P ; Kashyape, P ; Borbone, J ; Lording, A ; Pryde, K ; Cox, M ; Keslake, J ; Smith, M ; Cuthbertson, L ; Murugan, V ; Mackie, S ; Thomas, N.H ; Whitney, A ; Forrest, K.M ; Parker, A ; Forsyth, R ; Kipps, C.M</creator><creatorcontrib>Kirkham, F.J ; Haywood, P ; Kashyape, P ; Borbone, J ; Lording, A ; Pryde, K ; Cox, M ; Keslake, J ; Smith, M ; Cuthbertson, L ; Murugan, V ; Mackie, S ; Thomas, N.H ; Whitney, A ; Forrest, K.M ; Parker, A ; Forsyth, R ; Kipps, C.M</creatorcontrib><description>Abstract The literature on paediatric acute-onset movement disorders is scattered. In a prospective cohort of 52 children (21 male; age range 2mo-15y), the commonest were chorea, dystonia, tremor, myoclonus, and Parkinsonism in descending order of frequency. In this series of mainly previously well children with cryptogenic acute movement disorders, three groups were recognised: (1) Psychogenic disorders ( n  = 12), typically &gt;10 years of age, more likely to be female and to have tremor and myoclonus (2) Inflammatory or autoimmune disorders ( n  = 22), including N-methyl- d -aspartate receptor encephalitis, opsoclonus-myoclonus, Sydenham chorea, systemic lupus erythematosus, acute necrotizing encephalopathy (which may be autosomal dominant), and other encephalitides and (3) Non-inflammatory disorders ( n  = 18), including drug-induced movement disorder, post-pump chorea, metabolic, e.g. glutaric aciduria, and vascular disease, e.g. moyamoya. Other important non-inflammatory movement disorders, typically seen in symptomatic children with underlying aetiologies such as trauma, severe cerebral palsy, epileptic encephalopathy, Down syndrome and Rett syndrome, include dystonic posturing secondary to gastro-oesophageal reflux (Sandifer syndrome) and Paroxysmal Autonomic Instability with Dystonia (PAID) or autonomic ‘storming’. Status dystonicus may present in children with known extrapyramidal disorders, such as cerebral palsy or during changes in management e.g. introduction or withdrawal of neuroleptic drugs or failure of intrathecal baclofen infusion; the main risk in terms of mortality is renal failure from rhabdomyolysis. Although the evidence base is weak, as many of the inflammatory/autoimmune conditions are treatable with steroids, immunoglobulin, plasmapheresis, or cyclophosphamide, it is important to make an early diagnosis where possible. Outcome in survivors is variable. Using illustrative case histories, this review draws attention to the practical difficulties in diagnosis and management of this important group of patients.</description><identifier>ISSN: 1090-3798</identifier><identifier>EISSN: 1532-2130</identifier><identifier>DOI: 10.1016/j.ejpn.2011.04.005</identifier><identifier>PMID: 21835657</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Acute Disease ; Autoimmune Diseases of the Nervous System - mortality ; Autoimmune Diseases of the Nervous System - physiopathology ; Autoimmune Diseases of the Nervous System - therapy ; Biotin ; Brain Diseases, Metabolic, Inborn - mortality ; Brain Diseases, Metabolic, Inborn - physiopathology ; Brain Diseases, Metabolic, Inborn - therapy ; Cardiopulmonary bypass ; Child ; Chorea ; Comorbidity - trends ; Creatine ; Drugs ; Dyskinesia, Drug-Induced - mortality ; Dyskinesia, Drug-Induced - physiopathology ; Dyskinesia, Drug-Induced - therapy ; Dystonia ; Emergency Medical Services - standards ; Humans ; Infection ; Metabolic ; Movement Disorders - mortality ; Movement Disorders - physiopathology ; Movement Disorders - therapy ; Myoclonus ; Neuroleptic malignant syndrome ; Neurology ; Opsoclonus ; Organic aciduria ; Parkinsonism ; Paroxysmal Autonomic Instability with Dystonia ; Pediatrics ; Psychophysiologic Disorders - mortality ; Psychophysiologic Disorders - physiopathology ; Psychophysiologic Disorders - therapy ; Sandifer syndrome ; Status dystonicus ; Sydenham’s chorea ; Systemic lupus erythematosus ; Tremor ; Wilson’s disease</subject><ispartof>European journal of paediatric neurology, 2011-09, Vol.15 (5), p.390-404</ispartof><rights>European Paediatric Neurology Society</rights><rights>2011 European Paediatric Neurology Society</rights><rights>Copyright © 2011 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c442t-18938af6406e90ebe8c965c4a3d97937dba188ac735fa0f7afbeff1d39a7a9213</citedby><cites>FETCH-LOGICAL-c442t-18938af6406e90ebe8c965c4a3d97937dba188ac735fa0f7afbeff1d39a7a9213</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ejpn.2011.04.005$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,27922,27923,45993</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21835657$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kirkham, F.J</creatorcontrib><creatorcontrib>Haywood, P</creatorcontrib><creatorcontrib>Kashyape, P</creatorcontrib><creatorcontrib>Borbone, J</creatorcontrib><creatorcontrib>Lording, A</creatorcontrib><creatorcontrib>Pryde, K</creatorcontrib><creatorcontrib>Cox, M</creatorcontrib><creatorcontrib>Keslake, J</creatorcontrib><creatorcontrib>Smith, M</creatorcontrib><creatorcontrib>Cuthbertson, L</creatorcontrib><creatorcontrib>Murugan, V</creatorcontrib><creatorcontrib>Mackie, S</creatorcontrib><creatorcontrib>Thomas, N.H</creatorcontrib><creatorcontrib>Whitney, A</creatorcontrib><creatorcontrib>Forrest, K.M</creatorcontrib><creatorcontrib>Parker, A</creatorcontrib><creatorcontrib>Forsyth, R</creatorcontrib><creatorcontrib>Kipps, C.M</creatorcontrib><title>Movement disorder emergencies in childhood</title><title>European journal of paediatric neurology</title><addtitle>Eur J Paediatr Neurol</addtitle><description>Abstract The literature on paediatric acute-onset movement disorders is scattered. In a prospective cohort of 52 children (21 male; age range 2mo-15y), the commonest were chorea, dystonia, tremor, myoclonus, and Parkinsonism in descending order of frequency. In this series of mainly previously well children with cryptogenic acute movement disorders, three groups were recognised: (1) Psychogenic disorders ( n  = 12), typically &gt;10 years of age, more likely to be female and to have tremor and myoclonus (2) Inflammatory or autoimmune disorders ( n  = 22), including N-methyl- d -aspartate receptor encephalitis, opsoclonus-myoclonus, Sydenham chorea, systemic lupus erythematosus, acute necrotizing encephalopathy (which may be autosomal dominant), and other encephalitides and (3) Non-inflammatory disorders ( n  = 18), including drug-induced movement disorder, post-pump chorea, metabolic, e.g. glutaric aciduria, and vascular disease, e.g. moyamoya. Other important non-inflammatory movement disorders, typically seen in symptomatic children with underlying aetiologies such as trauma, severe cerebral palsy, epileptic encephalopathy, Down syndrome and Rett syndrome, include dystonic posturing secondary to gastro-oesophageal reflux (Sandifer syndrome) and Paroxysmal Autonomic Instability with Dystonia (PAID) or autonomic ‘storming’. Status dystonicus may present in children with known extrapyramidal disorders, such as cerebral palsy or during changes in management e.g. introduction or withdrawal of neuroleptic drugs or failure of intrathecal baclofen infusion; the main risk in terms of mortality is renal failure from rhabdomyolysis. Although the evidence base is weak, as many of the inflammatory/autoimmune conditions are treatable with steroids, immunoglobulin, plasmapheresis, or cyclophosphamide, it is important to make an early diagnosis where possible. Outcome in survivors is variable. Using illustrative case histories, this review draws attention to the practical difficulties in diagnosis and management of this important group of patients.</description><subject>Acute Disease</subject><subject>Autoimmune Diseases of the Nervous System - mortality</subject><subject>Autoimmune Diseases of the Nervous System - physiopathology</subject><subject>Autoimmune Diseases of the Nervous System - therapy</subject><subject>Biotin</subject><subject>Brain Diseases, Metabolic, Inborn - mortality</subject><subject>Brain Diseases, Metabolic, Inborn - physiopathology</subject><subject>Brain Diseases, Metabolic, Inborn - therapy</subject><subject>Cardiopulmonary bypass</subject><subject>Child</subject><subject>Chorea</subject><subject>Comorbidity - trends</subject><subject>Creatine</subject><subject>Drugs</subject><subject>Dyskinesia, Drug-Induced - mortality</subject><subject>Dyskinesia, Drug-Induced - physiopathology</subject><subject>Dyskinesia, Drug-Induced - therapy</subject><subject>Dystonia</subject><subject>Emergency Medical Services - standards</subject><subject>Humans</subject><subject>Infection</subject><subject>Metabolic</subject><subject>Movement Disorders - mortality</subject><subject>Movement Disorders - physiopathology</subject><subject>Movement Disorders - therapy</subject><subject>Myoclonus</subject><subject>Neuroleptic malignant syndrome</subject><subject>Neurology</subject><subject>Opsoclonus</subject><subject>Organic aciduria</subject><subject>Parkinsonism</subject><subject>Paroxysmal Autonomic Instability with Dystonia</subject><subject>Pediatrics</subject><subject>Psychophysiologic Disorders - mortality</subject><subject>Psychophysiologic Disorders - physiopathology</subject><subject>Psychophysiologic Disorders - therapy</subject><subject>Sandifer syndrome</subject><subject>Status dystonicus</subject><subject>Sydenham’s chorea</subject><subject>Systemic lupus erythematosus</subject><subject>Tremor</subject><subject>Wilson’s disease</subject><issn>1090-3798</issn><issn>1532-2130</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkU1LAzEYhIMoWqt_wIP0Jgi7vtlkPwIiSPELFA_qOaTJuzbrdlOTttB_b5ZWDx5ECCSBmWF4hpATCikFWlw0KTbzLs2A0hR4CpDvkAHNWZZklMFufIOAhJWiOiCHITQAIHhW7JODjFYsL_JyQM6f3Apn2C1GxgbnDfpR_Pp37LTFMLLdSE9ta6bOmSOyV6s24PH2HpK325vX8X3y-Hz3ML5-TDTn2SKhlWCVqgsOBQrACVZaFLnmihlRClaaiaJVpXTJ8lpBXap6gnVNDROqVCI2H5KzTe7cu88lhoWc2aCxbVWHbhmkAM5j_X8oYxMRT55HZbZRau9C8FjLubcz5deSguxhykb2MGUPUwKXEWY0nW7jl5MZmh_LN70ouNwIMOJYWfQyRGqdRmM96oU0zv6df_XLrlvbWa3aD1xjaNzSdxG0pDJkEuRLP2e_JqVxybIo2BdsKJlw</recordid><startdate>20110901</startdate><enddate>20110901</enddate><creator>Kirkham, F.J</creator><creator>Haywood, P</creator><creator>Kashyape, P</creator><creator>Borbone, J</creator><creator>Lording, A</creator><creator>Pryde, K</creator><creator>Cox, M</creator><creator>Keslake, J</creator><creator>Smith, M</creator><creator>Cuthbertson, L</creator><creator>Murugan, V</creator><creator>Mackie, S</creator><creator>Thomas, N.H</creator><creator>Whitney, A</creator><creator>Forrest, K.M</creator><creator>Parker, A</creator><creator>Forsyth, R</creator><creator>Kipps, C.M</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7TK</scope></search><sort><creationdate>20110901</creationdate><title>Movement disorder emergencies in childhood</title><author>Kirkham, F.J ; Haywood, P ; Kashyape, P ; Borbone, J ; Lording, A ; Pryde, K ; Cox, M ; Keslake, J ; Smith, M ; Cuthbertson, L ; Murugan, V ; Mackie, S ; Thomas, N.H ; Whitney, A ; Forrest, K.M ; Parker, A ; Forsyth, R ; Kipps, C.M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c442t-18938af6406e90ebe8c965c4a3d97937dba188ac735fa0f7afbeff1d39a7a9213</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Acute Disease</topic><topic>Autoimmune Diseases of the Nervous System - mortality</topic><topic>Autoimmune Diseases of the Nervous System - physiopathology</topic><topic>Autoimmune Diseases of the Nervous System - therapy</topic><topic>Biotin</topic><topic>Brain Diseases, Metabolic, Inborn - mortality</topic><topic>Brain Diseases, Metabolic, Inborn - physiopathology</topic><topic>Brain Diseases, Metabolic, Inborn - therapy</topic><topic>Cardiopulmonary bypass</topic><topic>Child</topic><topic>Chorea</topic><topic>Comorbidity - trends</topic><topic>Creatine</topic><topic>Drugs</topic><topic>Dyskinesia, Drug-Induced - mortality</topic><topic>Dyskinesia, Drug-Induced - physiopathology</topic><topic>Dyskinesia, Drug-Induced - therapy</topic><topic>Dystonia</topic><topic>Emergency Medical Services - standards</topic><topic>Humans</topic><topic>Infection</topic><topic>Metabolic</topic><topic>Movement Disorders - mortality</topic><topic>Movement Disorders - physiopathology</topic><topic>Movement Disorders - therapy</topic><topic>Myoclonus</topic><topic>Neuroleptic malignant syndrome</topic><topic>Neurology</topic><topic>Opsoclonus</topic><topic>Organic aciduria</topic><topic>Parkinsonism</topic><topic>Paroxysmal Autonomic Instability with Dystonia</topic><topic>Pediatrics</topic><topic>Psychophysiologic Disorders - mortality</topic><topic>Psychophysiologic Disorders - physiopathology</topic><topic>Psychophysiologic Disorders - therapy</topic><topic>Sandifer syndrome</topic><topic>Status dystonicus</topic><topic>Sydenham’s chorea</topic><topic>Systemic lupus erythematosus</topic><topic>Tremor</topic><topic>Wilson’s disease</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kirkham, F.J</creatorcontrib><creatorcontrib>Haywood, P</creatorcontrib><creatorcontrib>Kashyape, P</creatorcontrib><creatorcontrib>Borbone, J</creatorcontrib><creatorcontrib>Lording, A</creatorcontrib><creatorcontrib>Pryde, K</creatorcontrib><creatorcontrib>Cox, M</creatorcontrib><creatorcontrib>Keslake, J</creatorcontrib><creatorcontrib>Smith, M</creatorcontrib><creatorcontrib>Cuthbertson, L</creatorcontrib><creatorcontrib>Murugan, V</creatorcontrib><creatorcontrib>Mackie, S</creatorcontrib><creatorcontrib>Thomas, N.H</creatorcontrib><creatorcontrib>Whitney, A</creatorcontrib><creatorcontrib>Forrest, K.M</creatorcontrib><creatorcontrib>Parker, A</creatorcontrib><creatorcontrib>Forsyth, R</creatorcontrib><creatorcontrib>Kipps, C.M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Neurosciences Abstracts</collection><jtitle>European journal of paediatric neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kirkham, F.J</au><au>Haywood, P</au><au>Kashyape, P</au><au>Borbone, J</au><au>Lording, A</au><au>Pryde, K</au><au>Cox, M</au><au>Keslake, J</au><au>Smith, M</au><au>Cuthbertson, L</au><au>Murugan, V</au><au>Mackie, S</au><au>Thomas, N.H</au><au>Whitney, A</au><au>Forrest, K.M</au><au>Parker, A</au><au>Forsyth, R</au><au>Kipps, C.M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Movement disorder emergencies in childhood</atitle><jtitle>European journal of paediatric neurology</jtitle><addtitle>Eur J Paediatr Neurol</addtitle><date>2011-09-01</date><risdate>2011</risdate><volume>15</volume><issue>5</issue><spage>390</spage><epage>404</epage><pages>390-404</pages><issn>1090-3798</issn><eissn>1532-2130</eissn><abstract>Abstract The literature on paediatric acute-onset movement disorders is scattered. In a prospective cohort of 52 children (21 male; age range 2mo-15y), the commonest were chorea, dystonia, tremor, myoclonus, and Parkinsonism in descending order of frequency. In this series of mainly previously well children with cryptogenic acute movement disorders, three groups were recognised: (1) Psychogenic disorders ( n  = 12), typically &gt;10 years of age, more likely to be female and to have tremor and myoclonus (2) Inflammatory or autoimmune disorders ( n  = 22), including N-methyl- d -aspartate receptor encephalitis, opsoclonus-myoclonus, Sydenham chorea, systemic lupus erythematosus, acute necrotizing encephalopathy (which may be autosomal dominant), and other encephalitides and (3) Non-inflammatory disorders ( n  = 18), including drug-induced movement disorder, post-pump chorea, metabolic, e.g. glutaric aciduria, and vascular disease, e.g. moyamoya. Other important non-inflammatory movement disorders, typically seen in symptomatic children with underlying aetiologies such as trauma, severe cerebral palsy, epileptic encephalopathy, Down syndrome and Rett syndrome, include dystonic posturing secondary to gastro-oesophageal reflux (Sandifer syndrome) and Paroxysmal Autonomic Instability with Dystonia (PAID) or autonomic ‘storming’. Status dystonicus may present in children with known extrapyramidal disorders, such as cerebral palsy or during changes in management e.g. introduction or withdrawal of neuroleptic drugs or failure of intrathecal baclofen infusion; the main risk in terms of mortality is renal failure from rhabdomyolysis. Although the evidence base is weak, as many of the inflammatory/autoimmune conditions are treatable with steroids, immunoglobulin, plasmapheresis, or cyclophosphamide, it is important to make an early diagnosis where possible. Outcome in survivors is variable. Using illustrative case histories, this review draws attention to the practical difficulties in diagnosis and management of this important group of patients.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>21835657</pmid><doi>10.1016/j.ejpn.2011.04.005</doi><tpages>15</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1090-3798
ispartof European journal of paediatric neurology, 2011-09, Vol.15 (5), p.390-404
issn 1090-3798
1532-2130
language eng
recordid cdi_proquest_miscellaneous_904483521
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Acute Disease
Autoimmune Diseases of the Nervous System - mortality
Autoimmune Diseases of the Nervous System - physiopathology
Autoimmune Diseases of the Nervous System - therapy
Biotin
Brain Diseases, Metabolic, Inborn - mortality
Brain Diseases, Metabolic, Inborn - physiopathology
Brain Diseases, Metabolic, Inborn - therapy
Cardiopulmonary bypass
Child
Chorea
Comorbidity - trends
Creatine
Drugs
Dyskinesia, Drug-Induced - mortality
Dyskinesia, Drug-Induced - physiopathology
Dyskinesia, Drug-Induced - therapy
Dystonia
Emergency Medical Services - standards
Humans
Infection
Metabolic
Movement Disorders - mortality
Movement Disorders - physiopathology
Movement Disorders - therapy
Myoclonus
Neuroleptic malignant syndrome
Neurology
Opsoclonus
Organic aciduria
Parkinsonism
Paroxysmal Autonomic Instability with Dystonia
Pediatrics
Psychophysiologic Disorders - mortality
Psychophysiologic Disorders - physiopathology
Psychophysiologic Disorders - therapy
Sandifer syndrome
Status dystonicus
Sydenham’s chorea
Systemic lupus erythematosus
Tremor
Wilson’s disease
title Movement disorder emergencies in childhood
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T20%3A27%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Movement%20disorder%20emergencies%20in%20childhood&rft.jtitle=European%20journal%20of%20paediatric%20neurology&rft.au=Kirkham,%20F.J&rft.date=2011-09-01&rft.volume=15&rft.issue=5&rft.spage=390&rft.epage=404&rft.pages=390-404&rft.issn=1090-3798&rft.eissn=1532-2130&rft_id=info:doi/10.1016/j.ejpn.2011.04.005&rft_dat=%3Cproquest_cross%3E904483521%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=893993955&rft_id=info:pmid/21835657&rft_els_id=S1090379811000766&rfr_iscdi=true